A new panel of genes could pick out men at highest risk of developing prostate cancer and pick out those already diagnosed who are likely to have particularly aggressive forms of the disease, a large-scale genetic analysis has found.

Researchers at the ICR and The Royal Marsden have been named in a list of the world's most influential researchers.

A major new study of more than 140,000 men has identified 63 new genetic variations in the DNA code that increase the risk of prostate cancer.